Site: Pancreas

Inclusion Criteria:

• No Prior History of Pancreatic Cancer
• Cancer Free Non-Cases
• Valid DQX
• Has Serum Material
• Has 200ul Most Proximal Pre-DX Serum Within 5 Years of DX
• Matched at a 5-1 Ratio

Matching Factors:

• Gender
• Age at Randomization (5 year intervals)
• Race (W/B/O)
• Fiscal Year of Randomization (2 year groups with first group being 3 years)
• Year of Blood Draw

Match Ratio: 5 to 1

Match Technique: Individual matching only non-cases as controls.

Additional Matching Comments: Two non-cases desired year of draw were altered to handle match deficiencies.

Analytes:

• Anterior Gradient 2
• Cancer Antigen 19-9
• Carcinoembryonic antigen
• DIACETYLSPERMINE
• Indole-derivative
• Leucine Rich Alpha-2-Glycoprotein 1
• Lysophosphatidylcholine(18:0)
• Lysophosphatidylcholine(20:3)
• N8-ACETYLSPERMIDINE
• Regenerating Family Member 3 Alpha
• TIMP Metallopeptidase Inhibitor 1

Number of Cases: 175

Number of Controls: 875

---